EGFR and neoplasm: In xenograft mouse models, HIF1-α co-expression in CAR T cells targeting the receptor tyrosine kinase ErbB, which is expressed in both tumour and healthy organs, resulted in selective expansion of ErbB-targeting CAR T cells in the tumour, and ultimately tumour rejection with no associated on-target off-tumour toxicity.